Combinatorial strategies for alleviation of tumor-associated immune suppression and therapeutic vaccination against ovarian cancer

A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma

Dendritic cell (DC) vaccination with low dose temozolomide phase I/II trial in melanoma patients: Preliminary data on peripheral blood regulatory t-cells (Treg) and DC-TEM8 expression modulations.

Mature autologous dendritic cell vaccines in advanced non-small cell lung cancer: a phase I pilot study

Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer

Sipuleucel-T: autologous cellular immunotherapy for men with asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer

Recent advances in immunotherapy for the treatment of prostate cancer

Immunotherapy for prostate cancer: recent advances, lessons learned, and areas for further research

Improvement of dendritic cell therapy in glioblastoma multiforme WHO 4 by Newcastle disease virus.